MEDICA Newsletter
Social Media
More about…
- 3D-Druck
- Alternative Medizin
- Alzheimer
- Antibiotika
- Arthritis
- Arzneimittel
- Asthma
- Augen
- Baby
- Behandlung
- Beleuchtung
- Bildgebung
- Biofeedback
- Biokompatibel
- Biomarker
- Biotechnologie
- Blase
- Blut
- Brust
- COPD
- CT
- Chirurgie
- Darm
- Defibrillator
- Demenz
- Depression
- Desinfektion
- Diabetes
- Diagnostik
- EEG
- Elektronische Patientenakte
- Endoprothese
- Epilepsie
- Erbmaterial
- Fitness
- Forschung
- Frauen
- Früherkennung
- Geburt
- Gehirn
- Genetik
- Geräte
- Haut
- Herz
- Herz-Kreislauf
- Hirntumor
- Hygiene
- Immunsystem
- Impfung
- Implantat
- Infektionskrankheit
- Influenza
- Informationstechnologie
- Intensivmedizin
- Kinder
- Knie
- Krankenhaus
- Krebs
- Künstliche Intelligenz
- Labor
- Lunge
- MRT
- Magen
- Medizinische Apps
- Medizinmarkt
- Mikrosystemtechnik
- Minimal-Invasiv
- Nanotechnologie
- Neurologie
- Niere
- Operation
- Optimierung
- Optische Technologien
- Organe
- Orthopädie
- Parkinson
- Pathogene
- Pathologie
- Patienten
- Personalisierte Medizin
- Pflege
- Physiotherapie
- Prostata
- Prothese
- Qualität
- Radiologie
- Rauchen
- Regenerative Medizin
- Rehabilitation
- Risiken
- Robotik
- Röntgengeräte
- SARS-CoV-2/COVID-19
- Schlaf
- Schlaganfall
- Schmerzen
- Screening
- Sepsis
- Sicherheit
- Sinne
- Smart textiles
- Software
- Sport
- Stammzellen
- Stent
- Sterilisation
- Telemedizin
- Therapie
- Tissue Engineering
- USA
- Ultraschall
- Umwelt
- Virtual Reality
- Vorsorge
- Wearables
- Weltgesundheit
- Werkstoffe
- Wundheilung
- Zellen
- Ärzte
Gut enzyme could lead to new disease biomarker
12/08/2020
Enzymes used by bacteria to break down mucus in the gut could provide a useful biomarker for intestinal diseases, according to new research published in Nature Communications. Researchers at the University of Birmingham and Newcastle University have successfully identified and characterised one of the key enzymes involved in this process.
Blood test shows promise in the diagnosis of Alzheimer's
07/08/2020
A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer's disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive impairment, according to a large international study published in Journal of the American Medical Association (JAMA).
Lab profiles differentiate MIS-C from COVID-19 in children
06/08/2020
Findings show that MIS-C is a post-infectious syndrome distinct from Kawasaki disease and may help guide treatment decisions.
Non-invasive biomarkers to diagnose infant urinary tract obstruction
24/07/2020
One in every 500 babies is born with a condition called ureteropelvic junction obstruction, an obstruction of the ureter that prevents urine from flowing from one or both of the kidneys into the bladder. Diagnosed prenatally, UPJO can cause urinary tract infections; it can also result in chronic kidney disease and an increased risk for cardiovascular disease in later life.
Revealing lung disease with exhaled biomarkers
21/07/2020
Using specialized nanoparticles, MIT engineers have developed a way to monitor pneumonia or other lung diseases by analyzing the breath exhaled by the patient. In a study of mice, the researchers showed that they could use this system to monitor bacterial pneumonia, as well as a genetic disorder of the lungs called alpha-1 antitrypsin deficiency.
Adhesive film turns smartwatch into biochemical health monitoring system
25/06/2020
UCLA engineers have designed a thin adhesive film that could upgrade a consumer smartwatch into a powerful health-monitoring system. The system looks for chemical indicators found in sweat to give a real-time snapshot of what is happening inside the body. A study detailing the technology was published in the journal of Science Advances.
Biomarkers show clear signs of brain injury with severe COVID-19
23/06/2020
Certain patients who receive hospital care for coronavirus infection (COVID-19) exhibit clinical and neurochemical signs of brain injury, a University of Gothenburg study shows. In even moderate COVID-19 cases, finding and measuring a blood-based biomarker for brain damage proved to be possible.
Extraction of skin interstitial fluid using microneedle patches
05/06/2020
Researchers at the Terasaki Institute enhance tool for extraction of samples used in monitoring patient health.
Boost cancer treatment with new LAT1 inhibitor
18/05/2020
Researchers at the University of Eastern Finland have developed a new and promising drug compound for the treatment of cancer that inhibits natural amino acids from entering cancer cells. Since amino acids are essential for the growth and division of cancer cells, the new LAT1 inhibitor makes it possible to inhibit their growth. The study was published in the journal Apoptosis.
Cardiac diagnostics – prompt and personalized
08/11/2019
If physicians suspect an acute myocardial infarction, they first order an ECG. This test is very established and allows cardiologists to quickly diagnose acute heart attacks – though the test does not detect less common heart attack symptoms. So far, those patients had to wait up to twelve hours before a heart attack could be accurately diagnosed or ruled out. But things are about the change.
Early detection: Tattoo signals cancer – and more
09/07/2018
People who are not ill and do not show any symptoms typically do not visit the doctor. And while most people know that preventive medical checkups for cancer, for example, are important, they still avoid them. They tend to be very hesitant because the doctor might detect a serious illness. In the future, a new type of implant could make it easier to go to a screening test.
Personalized cancer medicine – Best possible treatment with TherapySelect
30/04/2018
Medicine is getting more and more personalized. This is particularly interesting for oncology, since a cancer is as individual as the respective patient. When choosing a therapy, both the characteristics of the tumor and the personal characteristics of the patient must be considered. To see exactly what this looks like, we visited the diagnostics company TherapySelect, based in Heidelberg.
Personalized medicine: a paradigm shift is gaining momentum
01/03/2018
Personalized medicine does not follow a "one-size-fits-all" treatment approach but emphasizes a "tailor-made" paradigm, meaning a treatment is customized to each individual person's case. For patients, this increases the chances of treatment success and means fewer side effects. While the approach originates in the field of oncology, it is now also increasingly applied to other disease patterns.